ECEZ yields 2000000.00% · JNJ yields 2.13%● Live data
📍 ECEZ pulled ahead of the other in Year 1
Combined, ECEZ + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ECEZ + JNJ for your $10,000?
Ecosciences, Inc. engages in the development, production, and sale of environmentally focused wastewater products to food and sanitation industries, as well as residential consumers in the United States and internationally. It produces organic tablets and powders to be used regularly and in lieu of harmful chemical cleaning products in grease trap and septic tank systems. The company provides bio-remediation services for sewers, sludge ponds, septic tanks, lagoons, farms, car washes, portable sanitation facilities, grease tanks, lakes, and ponds. Its products include Tank-Eze Wastewater Tablets, which provide active oxygen, nutrients, buffers, and safe aerobic microorganisms to clean, control odor, and keep wastewater systems running with reduced downtime; Trap-Eze Grease Trap Tablets that offer active oxygen, nutrients, buffers, and safe anaerobic and aerobic microorganisms to clean, deodorize, and keep grease traps running with reduced downtime; and Wash-Eze Car Wash Tablet, which reduces noxious odors, spotting, and other problems associated with the use of reclaimed water. The company primarily sells its products to municipalities, retail consumers, commercial and industrial users, food processors, hospitals, supermarkets, restaurants, and the janitorial supply industry through a network of master distributors, full line distributors, and sales representatives. Ecosciences, Inc. is based in Jericho, New York.
Full ECEZ Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.